Literature DB >> 22806204

Cost estimate of bovine tuberculosis to Ethiopia.

Rea Tschopp1, Jan Hattendorf, Felix Roth, Adnan Ali Khan Choudhury, Adnan Choudhoury, Alexandra Shaw, Abraham Aseffa, Jakob Zinsstag.   

Abstract

While bovine tuberculosis (BTB) has been eliminated in some industrialized countries, it prevails worldwide, particularly in Africa. In Ethiopia, BTB is prevalent as numerous studies have shown its occurrence in livestock and in abattoirs but it has not been demonstrated in wildlife and only very few cases have been found in humans. The objective of this study is to estimate the cost of BTB to Ethiopia with the aim of informing Ethiopian policy on options for BTB control. BTB in livestock affects both animal productivity and herd demographic composition. The Livestock Development Planning System (LDPS2, FAO) was modified to allow for stochastic simulation of parameters. We performed an incremental cost of disease analysis, comparing livestock production with and without BTB. For the rural scenario we considered an endemically stable 4 % comparative intradermal test (CIDT) prevalence and for the urban scenario an endemically stable 32 % CIDT prevalence among cattle. The net present value of rural Ethiopian livestock products in 2005 is estimated at 65.7 billion (thousand million) Ethiopian Birr (95 % Confidence Interval (CI) 53.8-77.7 billion Birr), which is the equivalent of 7.5 billion US$ (95 %CI 6.1-8.9 billion US$) at a rate of 8.7 Birr per US$ in 2005. The cost of BTB ranges from 646 million Birr (75.2 million US$) in 2005 to 3.1 Billion Birr in 2011 (358 million US$) but is within the range of uncertainty of our estimate and can thus not be distinguished from zero. The cost of disease in the urban livestock production ranges from 5 to 42 million Birr (500,000-4.9 million US$) between 2005 and 2011 but is also within the range of uncertainty of our estimate. Our study shows no measurable loss in asset value or cost of disease due to BTB in rural and urban production systems in Ethiopia. This does not mean that there is not a real cost of disease, but the variability of the productivity parameters and prices are high and would require more precise estimates. This study does not preclude in any way the urgent need to control BTB in the urban dairy herd of Addis Ababa for other than financial reasons.

Entities:  

Mesh:

Year:  2013        PMID: 22806204     DOI: 10.1007/82_2012_245

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  15 in total

Review 1.  Bovine tuberculosis in Ethiopia: A systematic review and meta-analysis.

Authors:  Berhanu Sibhat; Kassahun Asmare; Kassa Demissie; Gelagay Ayelet; Gezahegne Mamo; Gobena Ameni
Journal:  Prev Vet Med       Date:  2017-09-18       Impact factor: 2.670

2.  Cellular and Cytokine Responses in the Granulomas of Asymptomatic Cattle Naturally Infected with Mycobacterium bovis in Ethiopia.

Authors:  Begna Tulu; Henny M Martineau; Aboma Zewude; Fekadu Desta; David A Jolliffe; Markos Abebe; Taye Tolera Balcha; Mulugeta Belay; Adrian R Martineau; Gobena Ameni
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

3.  Bovine tuberculosis: prevalence and diagnostic efficacy of routine meat inspection procedure in Woldiya municipality abattoir north Wollo zone, Ethiopia.

Authors:  Alemu Aylate; Shahid Nazir Shah; Haileluel Aleme; Tarkegn Tintagu Gizaw
Journal:  Trop Anim Health Prod       Date:  2012-10-20       Impact factor: 1.559

4.  Molecular characterization of bovine tuberculosis strains in two slaughterhouses in Morocco.

Authors:  Hind Yahyaoui-Azami; Hamid Aboukhassib; Mohammed Bouslikhane; Jaouad Berrada; Soukaina Rami; Miriam Reinhard; Sebastien Gagneux; Julia Feldmann; Sonia Borrell; Jakob Zinsstag
Journal:  BMC Vet Res       Date:  2017-08-25       Impact factor: 2.741

5.  Transmission dynamics and elimination potential of zoonotic tuberculosis in morocco.

Authors:  Mahamat Fayiz Abakar; Hind Yahyaoui Azami; Philipp Justus Bless; Lisa Crump; Petra Lohmann; Mirjam Laager; Nakul Chitnis; Jakob Zinsstag
Journal:  PLoS Negl Trop Dis       Date:  2017-02-02

6.  The variable prevalence of bovine tuberculosis among dairy herds in Central Ethiopia provides opportunities for targeted intervention.

Authors:  Gizat Almaw; Andrew J K Conlan; Gobena Ameni; Balako Gumi; Alemseged Alemu; Sintayehu Guta; Solomon Gebre; Abebe Olani; Abebe Garoma; Dereje Shegu; Letebrhan Yimesgen; Demeke Nigussie; James L N Wood; Tamrat Abebe; Adane Mihret; Stefan Berg
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

7.  High prevalence of bovine tuberculosis in dairy cattle in central ethiopia: implications for the dairy industry and public health.

Authors:  Rebuma Firdessa; Rea Tschopp; Alehegne Wubete; Melaku Sombo; Elena Hailu; Girume Erenso; Teklu Kiros; Lawrence Yamuah; Martin Vordermeier; R Glyn Hewinson; Douglas Young; Stephen V Gordon; Mesfin Sahile; Abraham Aseffa; Stefan Berg
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

8.  Bovine tuberculosis and brucellosis prevalence in cattle from selected milk cooperatives in Arsi zone, Oromia region, Ethiopia.

Authors:  Rea Tschopp; Birhanu Abera; Sabi Yao Sourou; Emmanuelle Guerne-Bleich; Abraham Aseffa; Alehegne Wubete; Jakob Zinsstag; Douglas Young
Journal:  BMC Vet Res       Date:  2013-08-13       Impact factor: 2.741

Review 9.  Quantitative Outcomes of a One Health approach to Study Global Health Challenges.

Authors:  Laura C Falzon; Isabel Lechner; Ilias Chantziaras; Lucie Collineau; Aurélie Courcoul; Maria-Eleni Filippitzi; Riikka Laukkanen-Ninios; Carole Peroz; Jorge Pinto Ferreira; Merel Postma; Pia G Prestmo; Clare J Phythian; Eleonora Sarno; Gerty Vanantwerpen; Timothée Vergne; Douglas J C Grindlay; Marnie L Brennan
Journal:  Ecohealth       Date:  2018-01-12       Impact factor: 3.184

10.  An African origin for Mycobacterium bovis.

Authors:  Chloé Loiseau; Fabrizio Menardo; Abraham Aseffa; Elena Hailu; Balako Gumi; Gobena Ameni; Stefan Berg; Leen Rigouts; Suelee Robbe-Austerman; Jakob Zinsstag; Sebastien Gagneux; Daniela Brites
Journal:  Evol Med Public Health       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.